As we statesman our yearly wellness attraction recap bid this month, let's instrumentality a look backmost astatine the stories our readers liked most.
The most-read nonfiction connected HCPLive this twelvemonth was a summary of probe into the payment of real-time continuous glucose monitoring (CGM) connected HbA1c reduction.
Is that surprising? Maybe a small disappointing? What astir an nonfiction connected omega-3 fatty acids for atrial fibrillation (AFib) hazard reduction? A video interrogation connected bosom nonaccomplishment guidelines? These are hardly the outstanding headlines of 2022, yet they are among our astir fashionable posts successful these past 12 months.
We thin to judge the exceptional, the odd, oregon the exceptionally unusual are what get the astir attraction successful the news. In reality, the astir fashionable stories person a streak of commonality: what affects the astir volition beryllium work astir the most. Think astir those supra stories; fewer chronic diseases are arsenic prevalent and burdensome successful the US than diabetes and cardiovascular disease.
Now deliberation astir the intent of those articles: updates connected illness monitoring, hazard reduction, guidelines and strategies. Few things amended encapsulate the interests of our modern wellness attraction enactment unit than desires to amended manage, mitigate and hole for preventable disease. This each tracks with what our assemblage astir enjoyed from america this year.
This month, we privation to stock the ways however these commonly desired developments led to exceptional results successful medicine done 2022.
Welcome backmost to This Year In Medicine, HCPLive’s yearly recap bid that reflects connected the top stories, trends, issues and solutions successful each specialty of our coverage. Every Monday, Wednesday and Friday of December, our squad volition beryllium sharing stories and expert-driven contented that speaks to the large improvement of wellness care; from RSV to colon crab screening, from patient-reported outcomes to blindness-fighting drugs.
We’ll additionally beryllium sharing materials from our sister publications successful the greater HCPLive Network, highlighting the diverseness of our sum and the increasing interplay of specialty attraction teams:
- NeurologyLive
- Contagion
- CGTLive
- Contemporary Pediatrics
- Contemporary OB/GYN
You tin travel on the recap connected Facebook, Twitter and LinkedIn, utilizing the hashtag #ThisYearInMedicine, and each caller introduction volition beryllium shared connected the HCPLive homepage arsenic good arsenic done our regular newsletter.
We anticipation you bask reflecting connected the communal stories that came to mean overmuch much for medicine successful 2022. For now, cheque retired our 10 astir work stories of the year:
- Real-Time Continuous Glucose Monitoring Linked to Greater Reduction successful HbA1c
- Fish Oil Supplement Intake Influences Long-Term Atrial Fibrillation Risk
- Placebo Recipients successful COVID-19 Vaccine Trials Often Report Adverse Events
- FDA Approves First Ever Rapid-Acting Treatment for Major Depressive Disorder
- Phase 1/2 Trial Reports Positive Initial Clinical Data of VRDN-001 successful Thyroid Eye Disease
- Nihar Desai, MD, MPH: Improving PCSK9 Inhibitor Use, Guiding Heart Failure Care & ACC 2022 Headlines
- Comorbid Psychiatric Conditions Common for Adults With ADHD
- Glycemic Variability, High Glucose Increase Mortality Risk successful Patients with Type 2 Diabetes
- The Promising Future of Vitiligo Treatment
- Bentracimab Reverses Antiplatelet Bleeding Effect of Ticagrelor successful Phase 2b Trial
English (US)